Log in
Enquire now
‌

US Patent 8937182 Synthesis for thiazolidinedione compounds

Patent 8937182 was granted and assigned to Metabolic Solutions Development Company on January, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent

Patent attributes

Current Assignee
‌
Metabolic Solutions Development Company
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8937182
Date of Patent
January 20, 2015
Patent Application Number
13641917
Date Filed
April 18, 2011
Patent Citations Received
‌
US Patent 12084472 Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
3
Patent Primary Examiner
‌
Patricia L Morris
Patent abstract

The present invention provides novel methods for synthesizing PPARγ sparing compounds, e.g., thiazolidinediones, that are useful for preventing and/or treating metabolic disorders such as diabetes, obesity, hypertension, and inflammatory diseases.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8937182 Synthesis for thiazolidinedione compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.